Clinical Trial Update: Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of cetuximab for unresectable or metastatic esophageal and gastric cancer has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Esophageal Cancer, Gastric Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-05-14